Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2035-2043

  McAdam, E ^a   Haboubi, H N ^a   Forrester, G ^a   Eltahir, Z ^a   Spencer Harty, S ^b   Davies, C ^b   Griffiths, A P ^b   Baxter, J N ^b   Jenkins, G J S ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DEOXYCHOLIC ACID; FLUORESCENT DYE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; MESSENGER RNA; NITRIC OXIDE;

ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MICRONUCLEUS TEST; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH ACID; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; DEOXYCHOLIC ACID; DNA DAMAGE; ESOPHAGITIS, PEPTIC; ESOPHAGUS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOENZYME TECHNIQUES; MICRONUCLEUS TESTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84868611502     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs241     Document Type: Article

References (59)

1. Bhat, S. et al. (2011) Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J. Natl. Cancer Inst., 103, 1049-1057.
2. Jankowski, J.A. et al. (2002) Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology, 122, 588-590.
3. Denis, M. (1991) Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol., 49, 380-387.
4. Muñoz-Fernández, M.A. et al. (1992) Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett., 33, 35-40.
5. Vouldoukis, I. et al. (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc. Natl. Acad. Sci. U.S.A., 92, 7804-7808.
6. McInnes, I.B. et al. (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med., 184, 1519-1524.
7. Grabowski, P.S. et al. (1997) Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br. J. Rheumatol., 36, 651-655.
8. Bagasra, O. et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A., 92, 12041-12045.
9. Hamid, Q. et al. (1993) Induction of nitric oxide synthase in asthma. Lancet, 342, 1510-1513.
10. Kröncke, K.D. et al. (1991) Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun., 175, 752-758.
11. Eizirik, D.L. et al. (1996) Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol., 118, 71-83.
12. Vakkala, M. et al. (2000) Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin. Cancer Res., 6, 2408-2416.
13. Marrogi, A.J. et al. (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res., 6, 4739-4744.
14. Aaltoma, S.H. et al. (2001) Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res., 21(4B), 3101-3106.
15. Kojima, M. et al. (1999) Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol., 70, 222-229.
16. Wilson, K.T. et al. (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res., 58, 2929-2934.
17. Chen, T. et al. (2004) Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis. Cancer Res., 64, 3714-3717.
18. Kumagai, H. et al. (2004) Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis, 25, 723-727.
19. Burney, S. et al. (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res., 424, 37-49.
20. Clemons, N.J. et al. (2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology, 133, 1198-1209.
21. Dong, M. et al. (2006) Relatively small increases in the steady-state levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide. Chem. Res. Toxicol., 19, 50-57.
22. Jaiswal, M. et al. (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res., 60, 184-190.
23. Jaiswal, M. et al. (2001) Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology, 120, 190-199.
24. Jones, E.L. et al. (2009) Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase. Carcinogenesis, 30, 2123-2129.
25. Taylor, B.S. et al. (1998) Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem., 273, 15148-15156.
26. Pautz, A. et al. (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide, 23, 75-93.
27. Kleinert, H. et al. (1998) Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br. J. Pharmacol., 125, 193-201.
28. Kizaki, T. et al. (2001) Negative regulation of LPS-stimulated expression of inducible nitric oxide synthase by AP-1 in macrophage cell line J774A.1. Biochem. Biophys. Res. Commun., 289, 1031-1038.
29. Lander, H.M. et al. (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol., 150, 1509-1516.
30. Hierholzer, C. et al. (1998) Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med., 187, 917-928.
31. von Knethen, A. et al. (1999) NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell, 10, 361-372.
32. Pilz, R.B. et al. (1995) Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J., 9, 552-558.
33. Sciorati, C. et al. (1997) Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br. J. Pharmacol., 122, 687-697.
34. Mendes, A.F. et al. (2002) Role of nitric oxide in the activation of NF-kB, Ap-1 and NOSII expression in articular chondrocytes. Inflamm. Res. 51, 369-375.
35. Luss, H. et al. (1994) Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem. Biophys. Res. Commun., 204, 635-640.
36. Wilson, K.T. et al. (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 58, 2929-2934.
37. Vaninetti, N.M. et al. (2008) Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Mol. Carcinog., 47, 275-285.
38. Hirose, Y. et al. (2001) Modulation of inducible nitric oxide synthase expression in rat intestinal cells by colon tumor promoters. Int. J. Oncol., 18, 141-146.
39. Feagins, L.A. et al. (2008) Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am. J. Physiol. Gastrointest. Liver Physiol., 294, G411-G417.
40. Bae, J.D. et al. (2005) Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux. J. Korean Med. Sci., 20, 56-60.
41. Jolly, A.J. et al. (2009) Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells. Free Radic. Res., 43, 234-240.
42. Jenkins, G.J. et al. (2008) The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis, 23, 399-405.
43. Abdel-Latif, M.M. et al. (2004) NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann. Surg., 239, 491-500.
44. Jenkins, G.J. et al. (2007) Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers. J. Clin. Pathol., 60, 1232-1237.
45. Cronin, J. et al. (2010) The role of secondary bile acids in neoplastic development in the oesophagus. Biochem. Soc. Trans., 38, 337-342.
46. Lander, H.M. et al. (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol., 150, 1509-1516.
47. Hierholzer, C. et al. (1998) Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Ex. Med. 187, 917-928.
48. Jenkins, G.J. et al. (2004) The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25, 317-323.
49. Cronin, J. et al. (2011) Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). Am. J. Gastroenterol., 106, 46-56.
50. Schönfelder, G. et al. (1996) Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J., 10, 777-784.
51. Iijima, K. et al. (2002) Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology, 122, 1248-1257.
52. Mcoll, K.E. (2005) When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut, 54, 1-3.
53. Goldman, A. et al. (2010) A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus. Gut, 59, 1606-1616.
54. Gal, A. et al. (1996) Mutagenesis associated with nitric oxide production in transgenic SJL mice. Proc. Natl. Acad. Sci. U.S.A., 93, 15102-15107.
55. Forrester, K. et al. (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. U.S.A., 93, 2442-2447.
56. Casson, A.G. et al. (1994) Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am. J. Surg., 167, 52-57.
57. Prevo, L.J. et al. (1999) p53-mutant clones and field effects in Barrett's esophagus. Cancer Res., 59, 4784-4787.
58. Cobbs, C.S. et al. (2003) Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res., 63, 8670-8673.
59. Dvorak, K. et al. (2009) Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am. J. Gastroenterol., 104, 302-309.